ChromaDex Corporation (CDXC)
USD 7.87
(-0.88%)
USD 7.87
(-0.88%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 50.78 Million USD | 18.65% |
| 2022 | 42.79 Million USD | 3.15% |
| 2021 | 41.49 Million USD | 17.62% |
| 2020 | 35.27 Million USD | 36.89% |
| 2019 | 25.76 Million USD | 60.5% |
| 2018 | 16.05 Million USD | 53.24% |
| 2017 | 10.47 Million USD | -12.11% |
| 2016 | 11.92 Million USD | 40.56% |
| 2015 | 8.48 Million USD | 59.25% |
| 2014 | 5.32 Million USD | 69.98% |
| 2013 | 3.13 Million USD | 37.69% |
| 2012 | 2.27 Million USD | -7.94% |
| 2011 | 2.47 Million USD | -16.06% |
| 2010 | 2.94 Million USD | 44.25% |
| 2009 | 2.04 Million USD | 65.77% |
| 2008 | 1.23 Million USD | 0.0% |
| 2007 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 13.45 Million USD | 4.01% |
| 2024 Q3 | 16.24 Million USD | 18.6% |
| 2024 Q2 | 13.69 Million USD | 1.76% |
| 2023 FY | 50.78 Million USD | 18.65% |
| 2023 Q2 | 12.35 Million USD | -8.6% |
| 2023 Q4 | 12.93 Million USD | 8.09% |
| 2023 Q3 | 11.96 Million USD | -3.13% |
| 2023 Q1 | 13.51 Million USD | 12.5% |
| 2022 Q3 | 10.2 Million USD | 1.64% |
| 2022 Q4 | 12.01 Million USD | 17.72% |
| 2022 FY | 42.79 Million USD | 3.15% |
| 2022 Q1 | 10.53 Million USD | -3.09% |
| 2022 Q2 | 10.04 Million USD | -4.65% |
| 2021 Q2 | 10.81 Million USD | 17.07% |
| 2021 Q3 | 10.57 Million USD | -2.15% |
| 2021 Q4 | 10.86 Million USD | 2.74% |
| 2021 Q1 | 9.23 Million USD | -1.98% |
| 2021 FY | 41.49 Million USD | 17.62% |
| 2020 FY | 35.27 Million USD | 36.89% |
| 2020 Q3 | 8.45 Million USD | -6.98% |
| 2020 Q4 | 9.42 Million USD | 11.44% |
| 2020 Q2 | 9.08 Million USD | 9.35% |
| 2020 Q1 | 8.31 Million USD | 11.33% |
| 2019 Q1 | 5.3 Million USD | 12.52% |
| 2019 Q2 | 6.25 Million USD | 17.98% |
| 2019 Q3 | 6.74 Million USD | 7.91% |
| 2019 Q4 | 7.46 Million USD | 10.61% |
| 2019 FY | 25.76 Million USD | 60.5% |
| 2018 Q1 | 3.13 Million USD | -18.2% |
| 2018 Q2 | 3.84 Million USD | 22.6% |
| 2018 FY | 16.05 Million USD | 53.24% |
| 2018 Q3 | 4.36 Million USD | 13.39% |
| 2018 Q4 | 4.71 Million USD | 8.03% |
| 2017 FY | 10.47 Million USD | -12.11% |
| 2017 Q4 | 3.83 Million USD | 31.54% |
| 2017 Q3 | 2.91 Million USD | 28.84% |
| 2017 Q2 | 2.26 Million USD | 29.11% |
| 2017 Q1 | 1.75 Million USD | -23.79% |
| 2016 Q3 | 2.04 Million USD | -50.51% |
| 2016 Q4 | 2.29 Million USD | 12.6% |
| 2016 FY | 11.92 Million USD | 40.56% |
| 2016 Q2 | 4.12 Million USD | 19.59% |
| 2016 Q1 | 3.45 Million USD | 115.57% |
| 2015 FY | 8.48 Million USD | 59.25% |
| 2015 Q4 | 1.6 Million USD | -35.48% |
| 2015 Q3 | 2.48 Million USD | 0.44% |
| 2015 Q2 | 2.47 Million USD | 28.17% |
| 2015 Q1 | 1.92 Million USD | 35.85% |
| 2014 Q3 | 1.52 Million USD | 8.88% |
| 2014 FY | 5.32 Million USD | 69.98% |
| 2014 Q2 | 1.39 Million USD | 42.01% |
| 2014 Q1 | 985 Thousand USD | 31.44% |
| 2014 Q4 | 1.41 Million USD | -6.83% |
| 2013 Q2 | 960.73 Thousand USD | 42.79% |
| 2013 Q4 | 749.37 Thousand USD | -0.11% |
| 2013 Q3 | 750.18 Thousand USD | -21.92% |
| 2013 Q1 | 672.84 Thousand USD | -21.83% |
| 2013 FY | 3.13 Million USD | 37.69% |
| 2012 FY | 2.27 Million USD | -7.94% |
| 2012 Q3 | 1.25 Million USD | 64.02% |
| 2012 Q4 | 860.7 Thousand USD | -31.38% |
| 2012 Q2 | 764.69 Thousand USD | 226.56% |
| 2012 Q1 | -604.21 Thousand USD | -249.54% |
| 2011 Q1 | 1.02 Million USD | 20.26% |
| 2011 Q3 | 466.46 Thousand USD | -19.7% |
| 2011 Q4 | 404.03 Thousand USD | -13.38% |
| 2011 FY | 2.47 Million USD | -16.06% |
| 2011 Q2 | 580.91 Thousand USD | -43.07% |
| 2010 FY | 2.94 Million USD | 44.25% |
| 2010 Q1 | 817.97 Thousand USD | 32.86% |
| 2010 Q2 | 775.68 Thousand USD | -5.17% |
| 2010 Q3 | 502.72 Thousand USD | -35.19% |
| 2010 Q4 | 848.45 Thousand USD | 68.77% |
| 2009 Q4 | 615.66 Thousand USD | 28.25% |
| 2009 FY | 2.04 Million USD | 65.77% |
| 2009 Q3 | 480.04 Thousand USD | 0.5% |
| 2009 Q2 | 477.64 Thousand USD | 2.04% |
| 2009 Q1 | 468.07 Thousand USD | 67.82% |
| 2008 FY | 1.23 Million USD | 0.0% |
| 2008 Q4 | 278.91 Thousand USD | 49.02% |
| 2008 Q3 | 187.16 Thousand USD | -48.86% |
| 2008 Q2 | 365.98 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -33.544% |
| Alkermes plc | 1.37 Billion USD | 96.306% |
| Agenus Inc. | 139.61 Million USD | 63.629% |
| Aptorum Group Limited | -1.11 Million USD | 4655.535% |
| Ardelyx, Inc. | 106.66 Million USD | 52.391% |
| Dyadic International, Inc. | 922.95 Thousand USD | -5401.881% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -141.109% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 29143.199% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 480.151% |
| Novavax, Inc. | 639.93 Million USD | 92.065% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 208.414% |
| Pyxis Oncology, Inc. | -2 Million USD | 2639.0% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 9926.878% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -166.66% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 115018.077% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 9735.674% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 151.702% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -6231.671% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 62026.829% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 62.46% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -545.153% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 152.378% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 96.655% |
| AlloVir, Inc. | -398 Thousand USD | 12858.794% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 78.906% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -11876.415% |
| Bicycle Therapeutics plc | -129.52 Million USD | 139.206% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -42216.667% |
| Chimerix, Inc. | 324 Thousand USD | -15572.84% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 262.925% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 165.44% |
| CRISPR Therapeutics AG | 240.95 Million USD | 78.926% |
| Precision BioSciences, Inc. | 40.47 Million USD | -25.469% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 151.73% |
| Fortress Biotech, Inc. | 57.85 Million USD | 12.226% |
| Fortress Biotech, Inc. | 57.85 Million USD | 12.226% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -206.328% |
| ImmuCell Corporation | 4.39 Million USD | -1055.066% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 147.85% |
| Immix Biopharma, Inc. | -5468.00 USD | 928775.933% |
| Incyte Corporation | 3.44 Billion USD | 98.524% |
| Innoviva, Inc. | 261.06 Million USD | 80.549% |
| IO Biotech, Inc. | -756 Thousand USD | 6816.931% |
| Jaguar Health, Inc. | 7.72 Million USD | -557.431% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 7747.59% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 57.596% |
| ContextLogic Inc. | 59 Million USD | 13.932% |
| MiMedx Group, Inc. | 266.84 Million USD | 80.97% |
| MEI Pharma, Inc. | 49.32 Million USD | -2.946% |
| NextCure, Inc. | -3.68 Million USD | 1478.393% |
| Onconetix, Inc. | -1.12 Million USD | 4605.108% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 275.297% |
| Opthea Limited | 21.72 Thousand USD | -233693.738% |
| Psyence Biomedical Ltd. | -240.00 USD | 21158433.333% |
| Vaxcyte, Inc. | -75 Million USD | 167.707% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 88681.098% |
| Precigen, Inc. | 106 Thousand USD | -47805.66% |
| Pharming Group N.V. | 220.1 Million USD | 76.929% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -9760.194% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -4932.706% |
| PureTech Health plc | -1.6 Million USD | 3267.81% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 53.74% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 127.992% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 212.035% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 330.955% |
| Acelyrin, Inc. | -115 Thousand USD | 44256.522% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 505323.361% |
| Summit Therapeutics Inc. | -2.05 Million USD | 2577.073% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 8993.17% |
| Senti Biosciences, Inc. | -2.68 Million USD | 1992.657% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -1153.518% |
| Elevation Oncology, Inc. | -39 Thousand USD | 130305.128% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 1158.358% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 1388.163% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -74.328% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -10137.903% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 92427.273% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 51.22% |
| Seer, Inc. | 7.02 Million USD | -622.641% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -1059.89% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -135.693% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 42955.576% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 35535.901% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -8238.259% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 57.85% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 83.811% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 1015700.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -1872.805% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 100178.833% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -72.797% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 21987.931% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 10421.138% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 815.413% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 10800.777% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 488369.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -52083.206% |
| Century Therapeutics, Inc. | -10.8 Million USD | 569.794% |
| Kura Oncology, Inc. | -849 Thousand USD | 6081.154% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 175.674% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 34644.218% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 48.727% |
| Autolus Therapeutics plc | -4.86 Million USD | 1143.353% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -22.698% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 30326.19% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 46.391% |
| GRI Bio, Inc. | 10.84 Million USD | -368.407% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -1899.224% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 684.552% |
| IGM Biosciences, Inc. | -211.66 Million USD | 123.991% |
| INmune Bio, Inc. | 155 Thousand USD | -32661.29% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 18.016% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3471.195% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 7930.933% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 173564.508% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -12531.841% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 2644.088% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 16323.642% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 46.242% |
| Verastem, Inc. | -62 Thousand USD | 82003.226% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -1985.421% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 19555.939% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -1577.569% |
| Histogen Inc. | 3.76 Million USD | -1247.307% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -8713.233% |
| Surrozen, Inc. | -27.23 Million USD | 286.485% |
| Organovo Holdings, Inc. | -5.38 Million USD | 1042.29% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 4314.528% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 297.996% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -153.242% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 2564746.465% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -737.067% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 75743.145% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 67.194% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -34728.532% |
| Apollomics, Inc. | 127 Thousand USD | -39884.252% |
| Amarin Corporation plc | 165.54 Million USD | 69.325% |
| Mesoblast Limited | -9.81 Million USD | 617.371% |
| Turnstone Biologics Corp. | 16.5 Million USD | -207.646% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 145.959% |
| Synaptogenix, Inc. | -6347.00 USD | 800163.022% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 99668.627% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 68.531% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 97.111% |
| Better Therapeutics, Inc. | -2.72 Million USD | 1960.755% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 145.274% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 84.98% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 445226.227% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 911.182% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4683.032% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -593.905% |
| Insmed Incorporated | 239.63 Million USD | 78.809% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -1319.229% |
| OmniAb, Inc. | 14.66 Million USD | -246.219% |
| Alector, Inc. | -95.05 Million USD | 153.423% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 59.577% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 216.835% |
| Zai Lab Limited | 170.9 Million USD | 70.287% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 37.98% |
| Aura Biosciences, Inc. | -1.29 Million USD | 4021.236% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -38961.538% |
| Immunic, Inc. | -111 Thousand USD | 45847.748% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -220.298% |
| Veracyte, Inc. | 248.14 Million USD | 79.536% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 100.727% |
| FibroGen, Inc. | 128.9 Million USD | 60.606% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 9003646.099% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 535.249% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 98.506% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -12953.985% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 85.71% |
| TG Therapeutics, Inc. | 219.1 Million USD | 76.824% |
| Galecto, Inc. | -830 Thousand USD | 6218.072% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 3766.426% |
| Fortrea Holdings Inc. | 424 Million USD | 88.024% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 158.932% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 9055.908% |
| XBiotech Inc. | -1.74 Million USD | 3011.697% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 4683.032% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 209.272% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 167.228% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 30.82% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -202.208% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 86.947% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 202.282% |
| Vaxxinity, Inc. | -2.23 Million USD | 2373.053% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 84.459% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 548.434% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -107.681% |
| NexImmune, Inc. | -1.02 Million USD | 5054.282% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -940270.37% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 814.642% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.551% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 76087.251% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 1530.02% |
| Ainos, Inc. | -253.73 Thousand USD | 20113.163% |
| Pluri Inc. | 322 Thousand USD | -15670.186% |
| Prothena Corporation plc | -129.2 Million USD | 139.303% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -0.706% |
| Celularity Inc. | 6.75 Million USD | -651.739% |
| Rallybio Corporation | -150 Thousand USD | 33953.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 255.733% |
| MeiraGTx Holdings plc | 287 Thousand USD | -17593.38% |
| Omeros Corporation | -69.77 Million USD | 172.773% |
| Humacyte, Inc. | -76.55 Million USD | 166.336% |
| Immunocore Holdings plc | 248.39 Million USD | 79.556% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 434.762% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 18.598% |
| Blueprint Medicines Corporation | 236.58 Million USD | 78.536% |
| CalciMedica, Inc. | -58 Thousand USD | 87651.724% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 3661.01% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -74.772% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 1885.513% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 264.523% |
| Pulmatrix, Inc. | -8.22 Million USD | 717.762% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 4440.171% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 12826.817% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 112.733% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -1729.524% |
| Cytokinetics, Incorporated | -322.59 Million USD | 115.741% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -5790.234% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 14991.496% |
| Vor Biopharma Inc. | -3.49 Million USD | 1554.181% |
| Roivant Sciences Ltd. | 109.23 Million USD | 53.513% |
| Evogene Ltd. | 1.39 Million USD | -3529.736% |
| ProKidney Corp. | -3.16 Million USD | 1702.398% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 215.64% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -640.557% |
| CorMedix Inc. | -205.56 Thousand USD | 24803.009% |
| BioLineRx Ltd. | 1.1 Million USD | -4483.032% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 164.547% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 153978.788% |
| Atai Life Sciences N.V. | -5000.00 USD | 1015700.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 41771.112% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 52995.833% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 3755.868% |
| Sagimet Biosciences Inc. | 2 Million USD | -2439.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -5083.193% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 160.224% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 53804.193% |
| GeoVax Labs, Inc. | -20.72 Million USD | 345.068% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 79.234% |
| Biomea Fusion, Inc. | -4.2 Million USD | 1308.76% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 94.179% |
| Mereo BioPharma Group plc | 7.42 Million USD | -583.814% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 16480.645% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 423266.667% |
| Absci Corporation | -41.84 Million USD | 221.341% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1015700.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 166.489% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 2163.389% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 76.242% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 5496.387% |
| Allakos Inc. | -6.14 Million USD | 926.901% |
| Imunon, Inc. | -720 Thousand USD | 7152.729% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 173.598% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 89.33% |
| BioAtla, Inc. | -103.73 Million USD | 148.954% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 445226.227% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 28628.09% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 120.913% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 16427.974% |
| XOMA Corporation | 3.86 Million USD | -1215.203% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 172.455% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -243.247% |
| aTyr Pharma, Inc. | -2.38 Million USD | 2226.466% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -307.544% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 175203.448% |
| Viridian Therapeutics, Inc. | -1 Million USD | 5137.698% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -390615284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 1269600.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 92.027% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -25980.079% |
| UroGen Pharma Ltd. | 73.35 Million USD | 30.772% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 290.23% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -437281.568% |
| Orgenesis Inc. | -5.72 Million USD | 986.987% |
| Entera Bio Ltd. | -56 Thousand USD | 90778.571% |
| GH Research PLC | -315 Thousand USD | 16220.635% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 26967.725% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 9772.381% |
| Xencor, Inc. | -85.26 Million USD | 159.559% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 23079.767% |
| Replimune Group, Inc. | -2.65 Million USD | 2012.618% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 5171.731% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 71.447% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -25980.079% |
| Portage Biotech Inc. | -54 Thousand USD | 94137.037% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 53804.193% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 13569.496% |
| OncoCyte Corporation | 413 Thousand USD | -12195.4% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 1129799.666% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 22873973.874% |
| Purple Biotech Ltd. | -196 Thousand USD | 26008.163% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -466.236% |
| scPharmaceuticals Inc. | 9.78 Million USD | -419.117% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 586.168% |
| HilleVax, Inc. | -2.15 Million USD | 2455.288% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 52450.515% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 338543.082% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 7701.796% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 220882.609% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 676611.026% |
| Savara Inc. | -44.26 Million USD | 214.726% |
| Curis, Inc. | 9.81 Million USD | -417.582% |
| Daré Bioscience, Inc. | 2.76 Million USD | -1733.529% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 40793.015% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 3036.958% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 22371.93% |
| BeiGene, Ltd. | 2.07 Billion USD | 97.557% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 1916.231% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 112.706% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 10.422% |
| Erasca, Inc. | -3.73 Million USD | 1460.665% |
| bluebird bio, Inc. | -4.03 Million USD | 1360.05% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 180056.056% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 97.334% |
| DBV Technologies S.A. | 15.72 Million USD | -222.864% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 180056.056% |
| Moderna, Inc. | 2.15 Billion USD | 97.644% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 5649.727% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -534.274% |
| Molecular Templates, Inc. | 50.39 Million USD | -0.764% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 9573.881% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 62.044% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 916.136% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 229.07% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 145.695% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 1515.273% |
| MacroGenics, Inc. | 50.52 Million USD | -0.501% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 932.732% |
| Prime Medicine, Inc. | -147.9 Million USD | 134.333% |
| Aditxt, Inc. | -111.66 Thousand USD | 45577.342% |
| Adagene Inc. | 18.11 Million USD | -180.374% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -10305.738% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 63.781% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 67.827% |
| SciSparc Ltd. | 2.19 Million USD | -2212.386% |
| Vericel Corporation | 135.57 Million USD | 62.545% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 202822.664% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 164001.62% |
| Generation Bio Co. | -73.91 Million USD | 168.704% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 11720.137% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 7.029% |
| Invivyd, Inc. | -2.02 Million USD | 2603.945% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 116.879% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 49192.21% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 47.306% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 48.336% |
| ADMA Biologics, Inc. | 88.21 Million USD | 42.438% |
| Clene Inc. | 533 Thousand USD | -9427.205% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -110.625% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 5406.165% |
| GeoVax Labs, Inc. | -20.72 Million USD | 345.068% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -2454.326% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 26232.691% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -1.958% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 816.018% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 6174.163% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 39.124% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -69355.083% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 4.481% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 129.321% |
| Trevena, Inc. | 1.45 Million USD | -3390.034% |
| Surrozen, Inc. | -27.23 Million USD | 286.485% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 14485.269% |
| Cingulate Inc. | -582.91 Thousand USD | 8811.345% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 163906.452% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 357.78% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 670905.812% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 5863.905% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 92.54% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 5239.676% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 90228.146% |
| Kronos Bio, Inc. | 1.37 Million USD | -3601.166% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 194.622% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 17490.411% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 10499.047% |
| ImmunityBio, Inc. | -17.89 Million USD | 383.846% |
| Korro Bio, Inc. | -3.63 Million USD | 1498.898% |
| Kineta, Inc. | 5.43 Million USD | -834.659% |
| BioVie Inc. | -229.37 Thousand USD | 22238.227% |
| Codexis, Inc. | 57.33 Million USD | 11.431% |
| Celularity Inc. | 6.75 Million USD | -651.739% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -1165.387% |
| Celcuity Inc. | -142.77 Thousand USD | 35667.198% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -100275.568% |
| Cibus, Inc. | 1.42 Million USD | -3471.027% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 13677.54% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 321.563% |
| IN8bio, Inc. | -2.5 Million USD | 2130.388% |
| Kodiak Sciences Inc. | -25.94 Million USD | 295.707% |
| Annexon, Inc. | -3.26 Million USD | 1654.331% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 2584.344% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 221.667% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -7834.375% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 93.477% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 70.64% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 2772.632% |
| Arcellx, Inc. | 108.27 Million USD | 53.103% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 256.878% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 35.887% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 340.072% |
| Moolec Science SA | -143.3 Thousand USD | 35534.912% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 219.996% |
| Geron Corporation | -123.5 Million USD | 141.116% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -1444.874% |
| Royalty Pharma plc | 1.79 Billion USD | 97.169% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 172.45% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 1405969.324% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -21845.538% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 145.578% |
| Humacyte, Inc. | -76.55 Million USD | 166.336% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 5449.915% |
| 89bio, Inc. | -273 Thousand USD | 18700.733% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 4139.777% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 6088.208% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 41384.553% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -4437.98% |
| Notable Labs, Ltd. | 113 Thousand USD | -44838.053% |
| Liquidia Corporation | 14.6 Million USD | -247.808% |
| Mustang Bio, Inc. | -2.22 Million USD | 2382.247% |
| Immunovant, Inc. | -231 Thousand USD | 22082.684% |
| Quantum-Si incorporated | 488 Thousand USD | -10305.738% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 191.398% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 169366.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -2627.175% |
| Acasti Pharma Inc. | -11 Thousand USD | 461736.364% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 24917.097% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 7930.933% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 130.314% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -4375.665% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 13428.084% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 2693.463% |
| PepGen Inc. | -1.18 Million USD | 4388.851% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 40084.252% |
| United Therapeutics Corporation | 2.07 Billion USD | 97.547% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 321.776% |
| Solid Biosciences Inc. | -76.56 Million USD | 166.324% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 61589.653% |
| Immuneering Corporation | -764.13 Thousand USD | 6745.397% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -76532.862% |
| Belite Bio, Inc | -399 Thousand USD | 12826.817% |
| XOMA Corporation | 3.86 Million USD | -1215.203% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 353.444% |
| Bionomics Limited | -434.44 Thousand USD | 11788.368% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 4828.119% |
| uniQure N.V. | 2.21 Million USD | -2192.551% |
| Cassava Sciences, Inc. | -89.42 Million USD | 156.786% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 155.154% |
| Forte Biosciences, Inc. | -9000.00 USD | 564322.222% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 6181.437% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 11720.137% |
| Altimmune, Inc. | -65.37 Million USD | 177.677% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 85.974% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 4828.119% |
| Compugen Ltd. | 31.45 Million USD | -61.437% |
| Peak Bio, Inc. | 367.76 Thousand USD | -13707.58% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -107.13% |
| Benitec Biopharma Inc. | 108 Thousand USD | -46918.519% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 65202.564% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 4321.114% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 2887.047% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 42772.269% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 4321.114% |
| Instil Bio, Inc. | -4.75 Million USD | 1167.704% |
| argenx SE | 1.1 Billion USD | 95.419% |
| Immunome, Inc. | -8.9 Million USD | 670.113% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 2786.772% |
| Verona Pharma plc | -679.62 Thousand USD | 7571.779% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 29117.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | 2229.14% |
| CervoMed Inc. | -1.29 Million USD | 4025.397% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 2209.68% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 1163.01% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -1955.038% |
| Moolec Science SA | -143.3 Thousand USD | 35534.912% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 12545.163% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 2000.785% |
| AnaptysBio, Inc. | 14.78 Million USD | -243.549% |
| Design Therapeutics, Inc. | -537 Thousand USD | 9556.238% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 11992.272% |
| NeurAxis, Inc. | 2.15 Million USD | -2254.519% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -2266.263% |
| Lumos Pharma, Inc. | 2 Million USD | -2430.144% |
| Achilles Therapeutics plc | -4.73 Million USD | 1173.285% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 29117.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 48152.993% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -60.398% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -5790.234% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 5020.543% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 211.487% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -117993.023% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 6277.616% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 386024.913% |
| Palisade Bio, Inc. | 246 Thousand USD | -20542.276% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 153978.788% |
| Beam Therapeutics Inc. | -59.67 Million USD | 185.099% |
| Neurogene Inc. | -3.26 Million USD | 1656.714% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 63.555% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 1475.406% |
| Sesen Bio, Inc. | 40 Million USD | -26.95% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 17197.643% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 1360.977% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 630.838% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -260.653% |
| Athira Pharma, Inc. | -969 Thousand USD | 5340.454% |
| Vaccinex, Inc. | -16 Million USD | 417.296% |
| HCW Biologics Inc. | -574.82 Thousand USD | 8934.008% |
| XOMA Corporation | 3.86 Million USD | -1215.203% |
| Nektar Therapeutics | 53.47 Million USD | 5.045% |
| Arvinas, Inc. | 71.8 Million USD | 29.276% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 160.843% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 180.892% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 15870.186% |
| Rezolute, Inc. | -36 Thousand USD | 141155.556% |
| Clene Inc. | 533 Thousand USD | -9427.205% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 3954928.66% |
| BeyondSpring Inc. | 1.75 Million USD | -2800.057% |
| Synlogic, Inc. | -1.92 Million USD | 2739.293% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 137343.243% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 901.958% |
| Peak Bio, Inc. | 367.76 Thousand USD | -13707.58% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 367.785% |
| Krystal Biotech, Inc. | 47.6 Million USD | -6.669% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 64.009% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -910.547% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 2061.209% |
| MannKind Corporation | 136.19 Million USD | 62.714% |
| Ikena Oncology, Inc. | -50.49 Million USD | 200.57% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 53.333% |
| Gossamer Bio, Inc. | -4.38 Million USD | 1258.039% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 20250.794% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 1015700.0% |
| Legend Biotech Corporation | 140.92 Million USD | 63.968% |
| Mural Oncology plc | -2.56 Million USD | 2078.185% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 9315.971% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 50880.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -144.676% |
| REGENXBIO Inc. | 53.02 Million USD | 4.241% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 1047.927% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 26496.361% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 3031.871% |
| Vaxart, Inc. | -60.76 Million USD | 183.571% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 19424.149% |
| Cellectis S.A. | 18 Thousand USD | -282011.111% |
| Longeveron Inc. | 221 Thousand USD | -22877.376% |
| Repare Therapeutics Inc. | -80.07 Million USD | 163.42% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 95.354% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 4024.266% |
| Revolution Medicines, Inc. | -399.66 Million USD | 112.706% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 145185.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -103532.653% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 99.41% |
| Denali Therapeutics Inc. | -93.34 Million USD | 154.4% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 202822.664% |
| Veru Inc. | 7.56 Million USD | -571.167% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 33729.139% |
| Cingulate Inc. | -582.91 Thousand USD | 8811.345% |
| Passage Bio, Inc. | -3.72 Million USD | 1464.687% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 421720.724% |
| Exicure, Inc. | -1.42 Million USD | 3668.517% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 13358.486% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -1778.653% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 10004.911% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 25.462% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 34042.262% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 185.768% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -12887.212% |
| OmniAb, Inc. | 14.66 Million USD | -246.219% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -153.989% |
| Lipocine Inc. | -2.85 Million USD | 1881.243% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 2855.29% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 990.096% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 3471.195% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 32.577% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 78223.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 39.76% |
| Ocugen, Inc. | -33.53 Million USD | 251.415% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 1705.946% |
| Q32 Bio Inc. | 578 Thousand USD | -8685.467% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 19262.264% |
| Alumis Inc. Common Stock | -1.28 Million USD | 4054.829% |
| Equillium, Inc. | 35.95 Million USD | -41.22% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 3074.81% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -10042.227% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 1228450.266% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 19706.178% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -11912.907% |
| Dominari Holdings Inc. | 2.03 Million USD | -2390.436% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 27777.399% |
| vTv Therapeutics Inc. | -13.59 Million USD | 473.52% |
| Bio-Techne Corporation | 773.07 Million USD | 93.431% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -193.204% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 88.98% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 4443.884% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 311.76% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -334.128% |
| Nkarta, Inc. | -5.86 Million USD | 965.224% |
| BioCardia, Inc. | -7.24 Million USD | 800.51% |
| Iterum Therapeutics plc | -1.75 Million USD | 3001.714% |